4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-000214
Chief Accounting Officer sold 50,000 shares at an average $26.10 ($1,305,098)
- Chief Accounting Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lyon Joseph Douglas · Chief Accounting Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-30 | Exercise or conversion : show line 1 in the form | +4,167 | $3.88 | $16,168 | 4,167 | D |
| 2020-12-30 | Exercise or conversion : show line 2 in the form | +20,833 | $8.27 | $172,289 | 25,000 | D |
| 2020-12-30 | Sale : show line 3 in the form | −25,000 | $26.07 | $651,753 | 0 | D |
| 2021-01-04 | Exercise or conversion : show line 4 in the form | +25,000 | $8.27 | $206,750 | 25,000 | D |
| 2021-01-04 | Sale : show line 5 in the form | −25,000 | $26.13 | $653,345 | 0 | D |
| Open-market sales · 50,000 sh · avg $26.10 · $1,305,098 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-30 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −4,167 | 0 | D |
| 2020-12-30 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −20,833 | 79,167 | D |
| 2021-01-04 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −25,000 | 54,167 | D |
Loading xslF345X03/doc4.xml…